Bowhead Specialty (NYSE:BOW) Upgraded at Keefe, Bruyette & Woods

Keefe, Bruyette & Woods upgraded shares of Bowhead Specialty (NYSE:BOW) from a moderate buy rating to a strong-buy rating in a research report released on Monday,Zacks.com reports.

Other analysts also recently issued reports about the stock. Morgan Stanley dropped their price objective on shares of Bowhead Specialty from $31.00 to $29.00 and set an “equal weight” rating for the company in a report on Monday, November 17th. Piper Sandler raised their price target on Bowhead Specialty from $30.00 to $32.00 and gave the company an “overweight” rating in a research report on Monday, December 22nd. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Bowhead Specialty in a research note on Monday, December 29th. Zacks Research upgraded Bowhead Specialty from a “strong sell” rating to a “hold” rating in a report on Tuesday, February 24th. Finally, Royal Bank Of Canada reduced their price objective on Bowhead Specialty from $33.00 to $30.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 25th. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $33.33.

Bowhead Specialty Stock Down 3.3%

BOW stock opened at $22.04 on Monday. The company’s 50 day moving average is $24.45 and its 200 day moving average is $26.20. The stock has a market cap of $723.79 million, a price-to-earnings ratio of 13.86, a price-to-earnings-growth ratio of 0.69 and a beta of -1.06. The company has a current ratio of 0.52, a quick ratio of 0.52 and a debt-to-equity ratio of 0.33. Bowhead Specialty has a 1-year low of $21.92 and a 1-year high of $42.29.

Bowhead Specialty (NYSE:BOW) last announced its earnings results on Tuesday, February 24th. The company reported $0.47 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.45 by $0.02. Bowhead Specialty had a net margin of 9.75% and a return on equity of 13.27%. The business had revenue of $151.68 million during the quarter, compared to analyst estimates of $145.99 million. Sell-side analysts predict that Bowhead Specialty will post 1.36 EPS for the current fiscal year.

Institutional Trading of Bowhead Specialty

Several institutional investors have recently added to or reduced their stakes in the business. Y Intercept Hong Kong Ltd lifted its holdings in Bowhead Specialty by 47.3% in the 3rd quarter. Y Intercept Hong Kong Ltd now owns 133,958 shares of the company’s stock worth $3,622,000 after buying an additional 43,029 shares during the period. DAVENPORT & Co LLC grew its position in shares of Bowhead Specialty by 205.7% in the 3rd quarter. DAVENPORT & Co LLC now owns 269,769 shares of the company’s stock worth $7,295,000 after buying an additional 181,531 shares during the last quarter. American Century Companies Inc. increased its stake in shares of Bowhead Specialty by 1.6% during the second quarter. American Century Companies Inc. now owns 815,217 shares of the company’s stock valued at $30,595,000 after buying an additional 12,849 shares during the period. Victory Capital Management Inc. increased its stake in shares of Bowhead Specialty by 54.3% during the third quarter. Victory Capital Management Inc. now owns 1,525,285 shares of the company’s stock valued at $41,244,000 after buying an additional 536,817 shares during the period. Finally, Cynosure Group LLC bought a new position in shares of Bowhead Specialty during the second quarter valued at approximately $728,000.

Bowhead Specialty Company Profile

Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.